Clinical,Neuroimaging,and Genetic Markers in Cerebral Amyloid Angiopatny-Related Inflammation:A Systematic Review and Meta-Analusis
Stroke 54:178-188, Theodorou,A.,et al, 2023
A Case of Subacute Cognitive Decline in a 76-year-old Man
Neurol 87:e124-e128, MacLellan, A.,et al, 2016
Clinical Presentation of Chronic Traumatic Encephalopathy
Neurol 81:1122-1129, Stern, R.A.,et al, 2013
Serial MRI and CSF Biomarkers in Normal Aging, MCI, and AD
Neurol 75:143-151, Vemuri,P., et al, 2010
Incidence of Cerebral Microbleeds: A Longitudinal Study in Memory Clinic Population
Neurol 74:1954-1960, Goos,J.D.C., et al, 2010
Cerebral Amyloid Angiopathy
UpToDate: May 2010, Greenberg,S.M.,et al, 2010
Course of Cerebral Amyloid Angiopathy-Related Inflammation
Neurol 68:1411-1416, Kinnecom,C.,et al, 2007
Warfarin-Associated Hemorrhage and Cerebral Amyloid Angiopathy
Neurol 55:947-951, Rosand,J.,et al, 2000
Cerebral Amyloid Angiopathy:Propsects for Clinical Diagnosis and Treatment
Neurol 52:690-694, Greenberg,S.M., 1998
Clinicopath Conf
Cerebral Amyloid Angiopathy, Case 22-1996, NEJM 335:189-196996., , 1996
Plasma Levels of Apolipoprotein E and Risk of Dementia in the General Population
Ann Neurol 77:301-311, Rasmussen, K.L.,et al, 2015
Summary of Evidence-Based Guideline Update: Evaluation and Management of Concussion in Sports
Neurol 80:2250-2257, Giza, C.,et al, 2013
Predicting Alzheimer Disease with �-Amyloid Imaging: Results from the Australian Imaging, Biomarkers, and Lifestyle Study of Ageing
Ann Neurol 74:905-913, Rowe, C.C.,et al, 2013
Anti-Ab Autoantibodies in the CSF of a Patient With CAA-Related Inflammation: A Case Report
Neurol 76:842-844, DiFrancesco,J.C.,et al, 2011
Traumatic Brain Injury - Football, Warfare, and Long-Term Effects
NEJM 363:1293-1296, DeKosky,S.T.,et al, 2010
Genetic Aspects of Alzheimer Disease
The Neurologist 15:80-86, Williamson,J.,et al, 2009
Association of Parental Dementia With Cognitive and Brain MRI Measures in Middle-Aged Adults
Neurol 73:2071-2078, 2054, Debette,S.,et al, 2009
NSAID Use and Dementia Risk in the Cardiovascular Health Study: Role of APOE and NSAID Type
Neurol 70:17-24, Szekely,C.A.,et al, 2008
Joint Effect of Stroke and APOE 4 on Dementia Risk: The Canadian Study of Health and Aging
Neurol 70:9-16,5, Jin,Y.P.,et al, 2008
Prevalence and Risk Factors of Cerebral Microbleeds: The Rotterdam Scan Study
Neurol 70:1208-1214, Vernooij,M.W.,et al, 2008
Amateur Boxing and Risk of Chronic Traumatic Brain Injury: Systematic Review of Observational Studies
BMJ 335:809-812,781, Loosemore,M.,et al, 2007
Clinical Manifestations of Cerebral Amyloid Angiopathy-Related Inflammation
Ann Neurol 55:250-256, Eng,J.A.,et al, 2004
Apolipoprotein E Genotype and the Risk of Recurrent Lobar Intracerebral Hemorrhage
NEJM 342:240-245,276, O'Donnell,H.C.,et al, 2000
Patterns of Brain Activation in People at Risk for Alzheimer's Disease
NEJM 343:450-456,502, Bookheimer,S.Y. et al, 2000
Altered Brain Activation in Cognitively Intact Individuals at High Risk for Alzheimer's Disease
Neurol 53:1391-1396, Smith,C.D.,et al, 1999
The Clinical Introduction of Genetic Testing for Alzheimer Disease, An Ethical Perspective
JAMA 277:832-836, Post,S.G.,et al, 1997
High Frequency of Apolipoprotein E e2 Allele in Hemorrhage Due to Cerebral Amyloid Angiopathy
Ann Neurol 41:716-721, 7011997., Nicoli,J.A.R.,et al, 1997
Apolipoprotein E e4 Associated with Chronic Traumatic Brain Injury in Boxing
JAMA 278:136-140, Jordan,B.D.,et al, 1997
Genetic Testing for Alzheimer Disease, Practical and Ethical Issues
Arch Neurol 54:1226-1229, Roses,A.D., 1997
Association of Apolipoprotein E Polymorphism with Outcome after Head Injury
Lancet 350:1069-1071, Teasdale,G.M.,et al, 1997
Influence of Apolipoprotein E Genotype on Cerebral Amyloid Angiopathy in the Elderly
Stroke 27:216-218, Itoh,Y.,et al, 1996
Apolipoprotein E e4 is Associated with the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid Angiopathy
Stroke 27:1333-1337, Greenberg,S.M.,et al, 1996
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
The Challenge of the Dementias
Lancet 347:1301-1307, Eastwood,R.,et al, 1996
Genetic Factors in Alzheimer's Disease:A Review of Recent Advances
Ann Neurol 40:829-840, Levy-Lahad,E.&Bird,T.D., 1996
Apolipoprotein E Phenotype Freq & CSF Concentra are not Assoc with Creutzfeldt-Jakob Disease
Arch Neurol 53:1233-1238, Zerr,I.,et al, 1996
Decreased Hippocampal Volume Asymmetry on MRIs in Nondemented Elderly Subjects Carrying the Apolipoprotein E-4 Allele
Neurol 45:391-392, Soininen,H.,et al, 1995
Synergistic Effects of Traumatic Head Injury and Apolipoprotein-E4 In Patients with Alzheimer's Disease
Neurol 45:555-557, Mayeux,R.,et al, 1995
Apolipoprotein E e4 and Cerebral Hemorrhage Associated with Amyloid Angiopathy
Ann Neurol 38:254-259, Greenberg,S.M.,et al, 1995
Apolipoprotein E Allele E4, Dementia, and Cognitive Decline in a Population Sample
Lancet 346:1387-1390, Henderson,A.S.,et al, 1995
Statement of Use of Apolipoprotein E Testing for Alzheimer Disease
JAMA 274:1627-1629, Farrer,L.A.,et al, 1995
Apoliprprotein E E4 Allele & the Lifetime Risk of Alzheimer's Disease:What Physicians Know, & What They Should Know
Arch Neurol 52:1074-1079, Seshadri,S.,et al, 1995
Apolipoprotein E Genotype in Patients with Alzheimer's Disease:Implications for Risk of Dementia Among Relatives
Ann Neurol 38:797-808, Farrer,L.A.,et al, 1995